The promise of increased efficiency and minimal x-ray dose were enough to convince Dr. Matthew Wallis to choose Sectra Medical Systems five years ago when setting up a digital breast screening program in the U.K.
The promise of increased efficiency and minimal x-ray dose were enough to convince Dr. Matthew Wallis to choose Sectra Medical Systems five years ago when setting up a digital breast screening program in the U.K. Greg Freiherr has the video blog.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.